Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Novartis
Teva
Julphar
UBS
US Army
Federal Trade Commission
Express Scripts
Deloitte
Cipla

Generated: December 11, 2017

DrugPatentWatch Database Preview

Drugs with Dosage: FOR SUSPENSION, EXTENDED RELEASE;ORAL

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration Dosage
Nextwave PharmsQUILLIVANT XRmethylphenidate hydrochlorideFOR SUSPENSION, EXTENDED RELEASE;ORAL202100-001Sep 27, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► SubscribeFOR SUSPENSION, EXTENDED RELEASE;ORAL
Nextwave PharmsQUILLIVANT XRmethylphenidate hydrochlorideFOR SUSPENSION, EXTENDED RELEASE;ORAL202100-001Sep 27, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► SubscribeFOR SUSPENSION, EXTENDED RELEASE;ORAL
Nextwave PharmsQUILLIVANT XRmethylphenidate hydrochlorideFOR SUSPENSION, EXTENDED RELEASE;ORAL202100-001Sep 27, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► SubscribeFOR SUSPENSION, EXTENDED RELEASE;ORAL
Nextwave PharmsQUILLIVANT XRmethylphenidate hydrochlorideFOR SUSPENSION, EXTENDED RELEASE;ORAL202100-001Sep 27, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► SubscribeFOR SUSPENSION, EXTENDED RELEASE;ORAL
Nextwave PharmsQUILLIVANT XRmethylphenidate hydrochlorideFOR SUSPENSION, EXTENDED RELEASE;ORAL202100-001Sep 27, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► SubscribeFOR SUSPENSION, EXTENDED RELEASE;ORAL
Nextwave PharmsQUILLIVANT XRmethylphenidate hydrochlorideFOR SUSPENSION, EXTENDED RELEASE;ORAL202100-001Sep 27, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► SubscribeFOR SUSPENSION, EXTENDED RELEASE;ORAL
Nextwave PharmsQUILLIVANT XRmethylphenidate hydrochlorideFOR SUSPENSION, EXTENDED RELEASE;ORAL202100-001Sep 27, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► SubscribeFOR SUSPENSION, EXTENDED RELEASE;ORAL
Pf Prism CvZMAXazithromycinFOR SUSPENSION, EXTENDED RELEASE;ORAL050797-001Jun 10, 2005RXYesYes► Subscribe► Subscribe► SubscribeY► SubscribeFOR SUSPENSION, EXTENDED RELEASE;ORAL
Pf Prism CvZMAXazithromycinFOR SUSPENSION, EXTENDED RELEASE;ORAL050797-001Jun 10, 2005RXYesYes► Subscribe► Subscribe► SubscribeY► SubscribeFOR SUSPENSION, EXTENDED RELEASE;ORAL
Pf Prism CvZMAXazithromycinFOR SUSPENSION, EXTENDED RELEASE;ORAL050797-001Jun 10, 2005RXYesYes► Subscribe► Subscribe► SubscribeY► SubscribeFOR SUSPENSION, EXTENDED RELEASE;ORAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Harvard Business School
Cerilliant
Argus Health
Moodys
AstraZeneca
Chinese Patent Office
Merck
Express Scripts
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot